Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • Study 1415: Healthy Male and Female Particpants

    Research Purpose: Study 1415 is designed to evaluate an investigational drug being developed for the treatment of certain types of inflammatory conditions. A single dose of the investigational drug will be given as a subcutaneous injection (just under the skin) and will be compared to similar versions of the drug which are approved to be prescribed in the U.S. and Europe (adalimumab/Humira®).  The following will be evaluated:

    • How quickly the body process and eliminates the investigational drug compared to the U.S and E.U. approved versions
    • The safety/tolerability of the investigational drug compared to the U.S and E.U. approved versions
    • The body’s immune response to the investigational drug compared to the U.S and E.U. approved versions

    Minimum Screening Qualifications:


    Men are allowed to participate


    Women are allowed to participate


    18-45 years

    Body Mass Index (BMI)

    19 and 30.5


    Greater than 132 pounds

    Tobacco/Nicotine Use

    No tobacco/nicotine 24 hours prior to in-house stay or while at the research unit.  Use of tobacco/nicotine products at all other times during the study is allowed.

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 5 year of the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements not listed below

    Allowed Medications

    Acetaminophen and prescribed/stable hormonal birth control are allowed.


    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 10 ½ weeks. 

    Inpatient Stays

    • Participants will admit for an inpatient stay at Prism Clinical Research 1 time.
    • The inpatient stay will last approximately 8 ½ days (8 overnights)

    Outpatient Visits

    • There are at total of 9 outpatient visits
    • The outpatient visits will last between approximately 1-2 hours

     Compensation: Up to $2950.00

Recruitment and Volunteer Demographics

Prism Clinical Research recognizes the need to continually grow our diverse volunteer database populations. Through a multi-faceted enrollment process that includes a dedicated recruitment department, collaborative physician partnerships, advertising and subject referral programs, Prism Clinical Research can deliver Phase I-II results in the following populations:

  • HIV

  • Hepatic

  • Renal (Pre-ESRD, ESRD)

  • Type 2 Diabetes

  • Obesity

  • Healthy Male/Female/Elderly

  • Gilbert’s subset

  • Rheumatoid Arthritis

  • Epilepsy

  • Multiple Sclerosis
  • GI (IBS & Crohn’s)

  • Celiac
  • COPD, Allergy and Asthma

  • High Cholesterol

  • Hypertensive

  • Alzheimer's Disease
  • Ophthalmology

  • Slow Metabolizers

  • Osteoporosis
  • Osteoarthritis
  • Lupus

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.